The myasthenia gravis clinical trial analysis report delivers important insights into ongoing research of 30+ pipeline ...

Myasthenia gravis (MG) is a chronic autoimmune neuromuscular condition that causes muscle weakness and severe fatigue. There’s no cure for it, but available treatments can usually control symptoms, ...

Myasthenia gravis is a chronic autoimmune disorder that disrupts nerve-to-muscle signaling, causing weakness. Modern treatments help many people live typical life spans and enter remission.

A growing number of new treatments for myasthenia gravis (MG) are changing how doctors manage the disease and offering new options for people whose symptoms aren’t fully controlled. In recent years, ...

Snowflake disease is no laughing matter. While the term “snowflake” has been used to mock a fragile person who melts easily, ...

Once treated with a one-size-fits-all approach, changes in the landscape for myasthenia gravis are allowing for more precise treatment of the disease. In 2023, the FDA approved the 2 drugs to treat ...

When patients are undergoing treatment for cancer, clinicians should be aware of the potential to develop myasthenia gravis from immune checkpoint inhibitors (ICI), new research stresses, with ongoing ...

Christyn Edmundson, MD, is a neurology and neuromuscular medicine specialist with the Providence Swedish Neuroscience Institute in Seattle. Myasthenia gravis (MG) is a neuromuscular condition that can ...

Intravenous immunoglobulin (IVIG) is donor-derived antibodies used in myasthenia gravis (MG) for fast symptom control. It’s used for flares, maintenance, bridging slower therapies, or pre-surgery ...

Pregnancy does not increase the risk for exacerbations of myasthenia gravis, but the postpartum period is associated with a ...

Myasthenia gravis (MG) makes muscles feel weak and tire out fast. That weakness can affect muscles throughout the body, from the eyes and face to the neck and limbs. But the condition is also tied to ...